Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 Nov;18(11):608-11.
doi: 10.1023/a:1013165006406.

Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor

H Ali Hassan  1 , D El-Gezeiry, T M Nafaa, I Baghdady
Affiliations
Clinical Trial

Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor

H Ali Hassan et al. J Assist Reprod Genet. 2001 Nov.

Abstract

Purpose: To study the effect of CYP17a inhibitor, "ketoconazole," on clomiphene responsiveness in PCOS patients.

Methods: Prospective analysis was employed with the setup at Alexandria IVF/ICSI center. Ninety-seven insulin-resistant PCOS patients undergoing ovulation induction using clomiphene citrate were randomly divided, by random number table, into two groups. The first group (n = 49) received ketoconazole (400 mg daily) till correction of metabolic syndrome followed by clomiphene (100 mg/day); the second group (n = 48) receiving clomiphene without ketoconazole pretreatment. Main outcome measures were incidence of clomiphene resistance, monofollicular response, fasting insulin/glucose ratio, serum testosterone, and pregnancy rates.

Results: The ketoconazole group showed significantly (p < 0.05) higher incidence of monofollicular response (38%), higher pregnancy rates, and significantly less marked antiestrogenic manifestations than did the control group. They also had significantly lower incidence of clomiphene resistance (11.6%), lower serum testosterone levels, less hyperinsulinaemia, than did the control group.

Conclusion: Ketoconazole improved clomiphene responsivenss in PCOS patients and attenuated its untoward biological effects.

PubMed Disclaimer

References

    1. Zhang L, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20 lyase activity: Implications for adrenarche and polycystic ovarian syndromre. Proct Natl Acad Sci USA. 1995;92:10619. - PMC - PubMed
    1. Imani B, Eijekmans MJC, te Velde ER, Habbema JDF, Fauser BCJM. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotrophic oligomenorrhoeic infertility. J Clin Endocrinol Metab. 1998;83:2361. - PubMed
    1. Agrawal SK, Judd HL, Magoffin DA. A mechanism for the supression of estrogen production in PCOS. J Clin Endocrinol Metab. 1996;81:3686. - PubMed
    1. Jakimiuk AJ, Weitsman SR, Magoffin DA. 5-alpha reductase activity in women with PCOS. J Clin Endocrinol Metab. 1999;84(7):2414–2418. - PubMed
    1. Anderson E, Lee GY. The effects of DHEA and its metabolites on the PCO condition: Cystogenic changes of rat granulosa cells in vitro. Tissue Cell. 1996;28(6):673–685. - PubMed

Publication types

MeSH terms